Phospholipid Market by Source (Soy, Eggs, and Others), Form (Powder and Granule), and Application (Nutrition & Supplements, Pharmaceuticals, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

1.1.Key benefits for stakeholders

1.2.Key market segments

1.3.Research methodology

1.3.1.Secondary research

1.3.2.Primary research

1.3.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study

2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top impacting factors

3.2.2.Top investment pockets

3.3.Value chain analysis

3.4.Porter’s five forces analysis

3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Growing Demand for Naturally Sourced Ingredients

3.5.1.2.Increasing Demand for Phospholipid in the Pharmaceutical and Cosmetics Industries

3.5.2.Restraints

3.5.2.1.Genetically modified foods may act as a threat to the environment

3.5.3.Opportunities

3.5.3.1.Growing Demand for Alternate Sources of Phospholipid

3.5.3.2.Increase in demand for label-friendly products among consumers

3.6.Market share analysis

3.6.1.By source

3.6.2.By form

3.6.3.By application

3.6.4.By region

3.7.Parent/Peer Analysis

3.8.Impact of COVID-19 on the phospholipid market

CHAPTER 4:PHOSPHOLIPID MARKET, BY SOURCE

4.1.Overview

4.1.1.Market size and forecast

4.2.Soy

4.2.1.Key market trends, growth factors, and opportunities

4.2.2.Market size and forecast, by region

4.2.3.Market analysis, by country

4.3.Egg

4.3.1.Key market trends, growth factors, and opportunities

4.3.2.Market size and forecast, by region

4.3.3.Market analysis, by country

4.4.Others

4.4.1.Key market trends, growth factors, and opportunities

4.4.2.Market size and forecast, by region

4.4.3.Market analysis, by country

CHAPTER 5:PHOSPHOLIPID MARKET, FORM

5.1.Overview

5.1.1.Market size and forecast

5.2.Powder

5.2.1.Key market trends, growth factors, and opportunities

5.2.2.Market size and forecast, by region

5.2.3.Market analysis, by country

5.4.Granule

5.4.1.Key market trends, growth factors, and opportunities

5.4.2.Market size and forecast, by region

5.4.3.Market analysis, by country

CHAPTER 6:PHOSPHOLIPID MARKET, APPLICATION

6.1.Overview

6.1.1.Market size and forecast

6.2.Nutrition & supplements

6.2.1.Key market trends, growth factors, and opportunities

6.2.2.Market size and forecast, by region

6.2.3.Market analysis, by country

6.3.Pharmaceuticals

6.3.1.Key market trends, growth factors, and opportunities

6.3.2.Market size and forecast, by region

6.3.3.Market analysis, by country

6.4.Others

6.4.1.Key market trends, growth factors, and opportunities

6.4.2.Market size and forecast, by region

6.4.3.Market analysis, by country

CHAPTER 7:PHOSPHOLIPID MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast, by region

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities

7.2.2.Market size and forecast, by source

7.2.3.Market size and forecast, by form

7.2.4.Market size and forecast, by application

7.2.5.Market size and forecast, by country

7.2.5.1.U.S.

7.2.5.1.1.Market size and forecast, by source

7.2.5.1.2.Market size and forecast, by form

7.2.5.1.3.Market size and forecast, by application

7.2.5.2.Canada

7.2.5.2.1.Market size and forecast, by source

7.2.5.2.2.Market size and forecast, by form

7.2.5.2.3.Market size and forecast, by application

7.2.5.3.Mexico

7.2.5.3.1.Market size and forecast, by source

7.2.5.3.2.Market size and forecast, by form

7.2.5.3.3.Market size and forecast, by application

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities

7.3.2.Market size and forecast, by source

7.3.3.Market size and forecast, by form

7.3.4.Market size and forecast, by application

7.3.5.Market size and forecast, by country

7.3.5.1.Germany

7.3.5.1.1.Market size and forecast, by source

7.3.5.1.2.Market size and forecast, by form

7.3.5.1.3.Market size and forecast, by application

7.3.5.2.France

7.3.5.2.1.Market size and forecast, by source

7.3.5.2.2.Market size and forecast, by form

7.3.5.2.3.Market size and forecast, by application

7.3.5.3.UK

7.3.5.3.1.Market size and forecast, by source

7.3.5.3.2.Market size and forecast, by form

7.3.5.3.3.Market size and forecast, by application

7.3.5.4.Italy

7.3.5.4.1.Market size and forecast, by source

7.3.5.4.2.Market size and forecast, by form

7.3.5.4.3.Market size and forecast, by application

7.3.5.5.Spain

7.3.5.5.1.Market size and forecast, by source

7.3.5.5.2.Market size and forecast, by form

7.3.5.5.3.Market size and forecast, by application

7.3.5.6.Russia

7.3.5.6.1.Market size and forecast, by source

7.3.5.6.2.Market size and forecast, by form

7.3.5.6.3.Market size and forecast, by application

7.3.5.7.Rest of Europe

7.3.5.7.1.Market size and forecast, by source

7.3.5.7.2.Market size and forecast, by form

7.3.5.7.3.Market size and forecast, by application

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities

7.4.2.Market size and forecast, by source

7.4.3.Market size and forecast, by form

7.4.4.Market size and forecast, by application

7.4.5.Market size and forecast, by country

7.4.5.1.China

7.4.5.1.1.Market size and forecast, by source

7.4.5.1.2.Market size and forecast, by form

7.4.5.1.3.Market size and forecast, by application

7.4.5.2.Japan

7.4.5.2.1.Market size and forecast, by source

7.4.5.2.2.Market size and forecast, by form

7.4.5.2.3.Market size and forecast, by application

7.4.5.3.India

7.4.5.3.1.Market size and forecast, by source

7.4.5.3.2.Market size and forecast, by form

7.4.5.3.3.Market size and forecast, by application

7.4.5.4.Australia

7.4.5.4.1.Market size and forecast, by source

7.4.5.4.2.Market size and forecast, by form

7.4.5.4.3.Market size and forecast, by application

7.4.5.5.South Korea

7.4.5.5.1.Market size and forecast, by source

7.4.5.5.2.Market size and forecast, by form

7.4.5.5.3.Market size and forecast, by application

7.4.5.6.Thailand

7.4.5.6.1.Market size and forecast, by source

7.4.5.6.2.Market size and forecast, by form

7.4.5.6.3.Market size and forecast, by application

7.4.5.7.Singapore

7.4.5.7.1.Market size and forecast, by source

7.4.5.7.2.Market size and forecast, by form

7.4.5.7.3.Market size and forecast, by application

7.4.5.8.Rest of Asia-Pacific

7.4.5.8.1.Market size and forecast, by source

7.4.5.8.2.Market size and forecast, by form

7.4.5.8.3.Market size and forecast, by application

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities

7.5.2.Market size and forecast, by source

7.5.3.Market size and forecast, by form

7.5.4.Market size and forecast, by application

7.5.5.Market size and forecast, by country

7.5.5.1.Brazil

7.5.5.1.1.Market size and forecast, by source

7.5.5.1.2.Market size and forecast, by form

7.5.5.1.3.Market size and forecast, by application

7.5.5.2.Argentina

7.5.5.2.1.Market size and forecast, by source

7.5.5.2.2.Market size and forecast, by form

7.5.5.2.3.Market size and forecast, by application

7.5.5.3.UAE

7.5.5.3.1.Market size and forecast, by source

7.5.5.3.2.Market size and forecast, by form

7.5.5.3.3.Market size and forecast, by application

7.5.5.4.Nigeria

7.5.5.4.1.Market size and forecast, by source

7.5.5.4.2.Market size and forecast, by form

7.5.5.4.3.Market size and forecast, by application

7.5.5.5.South Africa

7.5.5.5.1.Market size and forecast, by source

7.5.5.5.2.Market size and forecast, by form

7.5.5.5.3.Market size and forecast, by application

7.5.5.6.Turkey

7.5.5.6.1.Market size and forecast, by source

7.5.5.6.2.Market size and forecast, by form

7.5.5.6.3.Market size and forecast, by application

7.5.5.7.Rest of LAMEA

7.5.5.7.1.Market size and forecast, by source

7.5.5.7.2.Market size and forecast, by form

7.5.5.7.3.Market size and forecast, by application

CHAPTER 8:COMPETITION LANDSCAPE

8.1.Top winning strategies

8.2.Product mapping

8.3.Competitive dashboard

8.4.Competitive heat map

8.5.Key developments

8.5.1.Acquisition

8.5.2.Business Expansion

8.5.3.Product Launch

CHAPTER 9:COMPANY PROFILES

9.1.ARCHER-DANIELS-MIDLAND COMPANY

9.1.1.Company overview

9.1.2.Key Executives

9.1.3.Company snapshot

9.1.4.Operating business segments

9.1.5.Product portfolio

9.1.6.Business performance

9.1.7.Key strategic moves and developments

9.2.Bunge Ltd.

9.2.1.Company overview

9.2.2.Key Executives

9.2.3.Company snapshot

9.2.4.Operating business segments

9.2.5.Product portfolio

9.2.6.Business performance

9.2.7.Key strategic moves and developments

9.3.Cargill, Incorporated

9.3.1.Company overview

9.3.2.Key Executives

9.3.3.Company snapshot

9.3.4.Operating business segments

9.3.5.Product portfolio

9.3.6.Business performance

9.4.DuPont de Nemours, Inc.

9.4.1.Company overview

9.4.2.Key executives

9.4.3.Company snapshot

9.4.4.Operating business segments

9.4.5.Product portfolio

9.4.6.R&D expenditure

9.4.7.Business performance

9.4.8.Key strategic moves and developments

9.5.Kewpie Corporation

9.5.1.Company overview

9.5.2.Key Executives

9.5.3.Company snapshot

9.5.4.Operating business segments

9.5.5.Product portfolio

9.5.6.R&D Expenditure

9.5.7.Business performance

9.6.Lasenor Emul SL

9.6.1.Company overview

9.6.2.Key Executives

9.6.3.Company snapshot

9.6.4.Product portfolio

9.6.5.Key strategic moves and developments

9.7.Lipoid GmbH

9.7.1.Company overview

9.7.2.Key Executives

9.7.3.Company snapshot

9.7.4.Product portfolio

9.8.SojaProtein a.d

9.8.1.Company overview

9.8.2.Key Executives

9.8.3.Company snapshot

9.8.4.Product portfolio

9.9.VAV Life Sciences Pvt. Ltd.

9.9.1.Company overview

9.9.2.Key Executives

9.9.3.Company snapshot

9.9.4.Product portfolio

9.9.5.Key strategic moves and developments

9.10.Wilmar International Ltd.

9.10.1.Company overview

9.10.2.Key Executives

9.10.3.Company snapshot

9.10.4.Operating business segments

9.10.5.Product portfolio

9.10.6.Business performance

TABLE 01.PHOSPHOLIPID MARKET REVENUE, BY SOURCE, 2020–2030 ($MILLION)

TABLE 02.SOY PHOSPHOLIPID MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)

TABLE 03.EGG PHOSPHOLIPID MARKET REVENUE, BY REGION 2020–2030 ($MILLION)

TABLE 04.OTHER PHOSPHOLIPID MARKET REVENUE, BY REGION 2020–2030 ($MILLION)

TABLE 05.PHOSPHOLIPID MARKET REVENUE, BY FORM, 2020–2030($MILLION)

TABLE 06.PHOSPHOLIPID MARKET REVENUE FOR POWDER, BY REGION, 2020–2030 ($MILLION)

TABLE 07.PHOSPHOLIPID MARKET REVENUE FOR GRANULE, BY REGION, 2020–2030 ($MILLION)

TABLE 08.PHOSPHOLIPID MARKET REVENUE, BY APPLICATION, 2020–2030($MILLION)

TABLE 09.PHOSPHOLIPID MARKET REVENUE FOR NUTRITION & SUPPLEMENTS, BY REGION, 2020–2030 ($MILLION)

TABLE 10.PHOSPHOLIPID MARKET REVENUE FOR PHARMACEUTICALS, BY REGION, 2020–2030 ($MILLION)

TABLE 11.PHOSPHOLIPID MARKET REVENUE FOR OTHERS, BY REGION, 2020–2030 ($MILLION)

TABLE 12.PHOSPHOLIPID MARKET, BY REGION, 2020–2030 ($MILLION)

TABLE 13.NORTH AMERICA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 14.NORTH AMERICA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 15.NORTH AMERICA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 16.NORTH AMERICA PHOSPHOLIPID MARKET, BY COUNTRY, 2020–2030 ($MILLION)

TABLE 17.U.S. PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 18.U.S. PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 19.U.S. PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 20.CANADA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 21.CANADA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 22.CANADA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 23.MEXICO PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 24.MEXICO PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 25.MEXICO PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 26.EUROPE PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 27.EUROPE PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 28.EUROPE PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 29.EUROPE PHOSPHOLIPID MARKET, BY COUNTRY, 2020–2030 ($MILLION)

TABLE 30.GERMANY PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 31.GERMANY PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 32.GERMANY PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 33.FRANCE PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 34.FRANCE PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 35.FRANCE PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 36.UK PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 37.UK PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 38.UK PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 39.ITALY PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 40.ITALY PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 41.ITALY PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 42.SPAIN PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 43.SPAIN PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 44.SPAIN PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 45.RUSSIA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 46.RUSSIA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 47.RUSSIA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 48.REST OF EUROPE PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 49.REST OF EUROPE PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 50.REST OF EUROPE PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 51.ASIA-PACIFIC PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 52.ASIA-PACIFIC PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 53.ASIA-PACIFIC PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 54.ASIA-PACIFIC PHOSPHOLIPID MARKET, BY COUNTRY, 2020–2030 ($MILLION)

TABLE 55.CHINA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 56.CHINA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 57.CHINA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 58.JAPAN PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 59.JAPAN PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 60.JAPAN PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 61.INDIA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 62.INDIA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 63.INDIA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 64.AUSTRALIA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 65.AUSTRALIA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 66.AUSTRALIA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 67.SOUTH KOREA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 68.SOUTH KOREA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 69.SOUTH KOREA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 70.THAILAND PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 71.THAILAND PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 72.THAILAND PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 73.SINGAPORE PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 74.SINGAPORE PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 75.SINGAPORE PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 76.REST OF ASIA-PACIFIC PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 77.REST OF ASIA-PACIFIC PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 78.REST OF ASIA-PACIFIC PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 79.LAMEA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 80.LAMEA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 81.LAMEA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 82.LAMEA PHOSPHOLIPID MARKET, BY COUNTRY, 2020–2030 ($MILLION)

TABLE 83.BRAZIL PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 84.BRAZIL PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 85.BRAZIL PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 86.ARGENTINA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 87.ARGENTINA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 88.ARGENTINA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 89.UAE PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 90.UAE PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 91.UAE PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 92.NIGERIA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 93.NIGERIA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 94.NIGERIA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 95.SOUTH AFRICA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 96.SOUTH AFRICA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 97.SOUTH AFRICA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 98.TURKEY PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 99.TURKEY PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 100.TURKEY PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 101.REST OF LAMEA PHOSPHOLIPID MARKET, BY SOURCE, 2020–2030 ($MILLION)

TABLE 102.REST OF LAMEA PHOSPHOLIPID MARKET, BY FORM, 2020–2030 ($MILLION)

TABLE 103.REST OF LAMEA PHOSPHOLIPID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 104.ARCHER-DANIELS-MIDLAND COMPANY: KEY EXECUTIVES

TABLE 105.ARCHER-DANIELS-MIDLAND COMPANY: COMPANY SNAPSHOT

TABLE 106.ARCHER-DANIELS-MIDLAND COMPANY: OPERATING SEGMENTS

TABLE 107.ARCHER-DANIELS-MIDLAND COMPANY: PRODUCT PORTFOLIO

TABLE 108.ARCHER-DANIELS-MIDLAND COMPANY: NET SALES, 2017–2019 ($MILLION)

TABLE 109.BUNGE LTD.: KEY EXECUTIVES

TABLE 110.BUNGE LTD.: COMPANY SNAPSHOT

TABLE 111.BUNGE LTD.: OPERATING SEGMENTS

TABLE 112.BUNGE LTD.: PRODUCT PORTFOLIO

TABLE 113.BUNGE LTD.: NET SALES, 2018–2020 ($MILLION)

TABLE 114.CARGILL, INCORPORATED: KEY EXECUTIVES

TABLE 115.CARGILL, INCORPORATED: COMPANY SNAPSHOT

TABLE 116.CARGILL, INCORPORATED: OPERATING SEGMENTS

TABLE 117.CARGILL, INCORPORATED: PRODUCT PORTFOLIO

TABLE 118.CARGILL, INCORPORATED: NET SALES, 2018–2020 ($MILLION)

TABLE 119.DUPONT DE NEMOURS, INC.: KEY EXECUTIVES

TABLE 120.DUPONT DE NEMOURS, INC.: COMPANY SNAPSHOT

TABLE 121.DUPONT DE NEMOURS, INC.: OPERATING SEGMENTS

TABLE 122.DUPONT DE NEMOURS, INC.: PRODUCT PORTFOLIO

TABLE 123.DUPONT DE NEMOURS, INC.: R&D EXPENDITURE, 2018–2020 ($MILLION)

TABLE 124.DUPONT DE NEMOURS, INC.: NET SALES, 2018–2020 ($MILLION)

TABLE 125.KEWPIE CORPORATION: KEY EXECUTIVES

TABLE 126.KEWPIE CORPORATION: COMPANY SNAPSHOT

TABLE 127.KEWPIE CORPORATION: OPERATING SEGMENTS

TABLE 128.KEWPIE CORPORATION: PRODUCT PORTFOLIO

TABLE 129.KEWPIE CORPORATION: R&D EXPENDITURE, 2018–2020 ($MILLION)

TABLE 130.KEWPIE CORPORATION: NET SALES, 2018–2020 ($MILLION)

TABLE 131.LASENOR EMUL SL: KEY EXECUTIVES

TABLE 132.LASENOR EMUL SL: COMPANY SNAPSHOT

TABLE 133.LASENOR EMUL SL: PRODUCT PORTFOLIO

TABLE 134.LIPOID GMBH: KEY EXECUTIVES

TABLE 135.LIPOID GMBH: COMPANY SNAPSHOT

TABLE 136.LIPOID GMBH: PRODUCT PORTFOLIO

TABLE 137.SOJAPROTEIN A.D: KEY EXECUTIVES

TABLE 138.SOJAPROTEIN A.D: COMPANY SNAPSHOT

TABLE 139.SOJAPROTEIN A.D: PRODUCT PORTFOLIO

TABLE 140.VAV LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES

TABLE 141.VAV LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT

TABLE 142.VAV LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO

TABLE 143.WILMAR INTERNATIONAL LTD.: KEY EXECUTIVES

TABLE 144.WILMAR INTERNATIONAL LTD.: COMPANY SNAPSHOT

TABLE 145.WILMAR INTERNATIONAL LTD.: OPERATING SEGMENTS

TABLE 146.WILMAR INTERNATIONAL LTD.: PRODUCT PORTFOLIO

TABLE 147.WILMAR INTERNATIONAL LTD.: NET SALES, 2018–2020 ($MILLION)